Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021
Jochem B. Buil(Radboud University Nijmegen), Paul E. Verweij(Radboud University Nijmegen), Abraham Goorhuis, Arthur R. H. van Zanten(Ziekenhuis Gelderse Vallei), Jeroen A Janson(Leiden University Medical Center), Robbert G. Bentvelsen(Amphia Ziekenhuis), Linda J. Wammes(Leiden University Medical Center), Ed J. Kuijper(Leiden University Medical Center), Moniek Heusinkveld(Ziekenhuis Gelderse Vallei), Max Melchers(Ziekenhuis Gelderse Vallei), Willem J. G. Melchers(Radboud University Nijmegen), Sanne van der Voort, Tom A. Rijpstra(Amphia Ziekenhuis)
Cited by 74
Related Papers
ESPEN guideline on clinical nutrition in the intensive care unit
|Clinical Nutrition|2018|2.8k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
|Clinical Microbiology and Infection|2018|1.5k
Decontamination of the Digestive Tract and Oropharynx in ICU Patients
|New England Journal of Medicine|2008|823